Source: Health Products Regulatory Authority (IE) Revision Year: 2007 Publisher: Norgine Limited, Chaplin House, Widewater Place, Moorhall Road, Harefield, Uxbridge, Middlesex, UB9 6NS, Untied Kingdom
Pyralvex Oromucosal Solution.
| Pharmaceutical Form |
|---|
|
Brown oromucosal solution. |
Pyralvex contains the following active substances in each 1ml of solution:
Rhubarb extract 50 mg (equivalent to 5 mg anthraquinone glycosides)
Salicylic acid 10 mg
For excipients, see 6.1.
| Active Ingredient |
|---|
|
|
|
Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. |
| List of Excipients |
|---|
|
Ethanol |
An amber glass bottle with brush applicator (PP screw cap with PE stem and nylon filament brush), containing 10 ml of solution.
Norgine Limited, Chaplin House, Widewater Place, Moorhall Road, Harefield, Uxbridge, Middlesex, UB9 6NS, Untied Kingdom
PA 102/15/1
Date of first authorisation: 1st April 1983
Date of last renewal: 1st April 2003
| Drug | Countries | |
|---|---|---|
| PYRALVEX | Ecuador, Spain, France, Singapore, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.